Leidos (NYSE:LDOS – Get Free Report) had its price objective lowered by research analysts at Truist Financial from $165.00 to $155.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the aerospace company’s stock. Truist Financial’s price target would indicate a potential upside of 9.54% from the company’s current price.
LDOS has been the topic of several other reports. UBS Group reduced their price target on Leidos from $162.00 to $156.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 12th. Cantor Fitzgerald upgraded shares of Leidos to a “strong-buy” rating in a report on Tuesday, February 25th. Wells Fargo & Company dropped their price objective on shares of Leidos from $191.00 to $173.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 8th. TD Cowen lowered Leidos from a “buy” rating to a “hold” rating and reduced their price objective for the company from $200.00 to $165.00 in a research report on Wednesday, January 8th. Finally, William Blair lowered Leidos from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Five equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.23.
Check Out Our Latest Stock Report on Leidos
Leidos Trading Down 1.0 %
Leidos (NYSE:LDOS – Get Free Report) last announced its earnings results on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.13. Leidos had a return on equity of 30.93% and a net margin of 7.53%. As a group, research analysts anticipate that Leidos will post 10.62 EPS for the current year.
Insider Buying and Selling
In other Leidos news, Director Robert C. Kovarik, Jr. sold 1,511 shares of Leidos stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $134.56, for a total value of $203,320.16. Following the completion of the transaction, the director now directly owns 6,408 shares of the company’s stock, valued at $862,260.48. The trade was a 19.08 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Gary Stephen May sold 2,128 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $131.24, for a total value of $279,278.72. Following the transaction, the director now directly owns 11,264 shares of the company’s stock, valued at $1,478,287.36. The trade was a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by insiders.
Institutional Trading of Leidos
A number of hedge funds and other institutional investors have recently bought and sold shares of LDOS. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of Leidos in the 4th quarter valued at about $25,000. Duncker Streett & Co. Inc. purchased a new position in shares of Leidos in the 4th quarter valued at approximately $27,000. REAP Financial Group LLC raised its stake in shares of Leidos by 422.2% during the fourth quarter. REAP Financial Group LLC now owns 188 shares of the aerospace company’s stock worth $27,000 after purchasing an additional 152 shares during the last quarter. Berbice Capital Management LLC purchased a new position in Leidos during the 4th quarter worth $29,000. Finally, Mather Group LLC. lifted its position in Leidos by 143.1% in the fourth quarter. Mather Group LLC. now owns 265 shares of the aerospace company’s stock valued at $38,000 after purchasing an additional 156 shares during the period. 76.12% of the stock is currently owned by institutional investors and hedge funds.
About Leidos
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Articles
- Five stocks we like better than Leidos
- How to Evaluate a Stock Before Buying
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- 3 Dividend Kings To Consider
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- How to Invest in Biotech Stocks
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.